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Abstract 19 
 20 
Propranolol (PRO), a human β-AR (β-adrenergic receptor) antagonist, is considered to result 21 
in specific effects in a non-target species, D. magna, based on our previous studies. The 22 
present study investigated the effects of β-AR agents, including an antagonist and agonist 23 
using pharmacologically relevant endpoints as well as a more holistic gene expression 24 
approach to reveal the impacts and potential mode of actions (MOAs) in the model non-target 25 
species. Results show that the responses in cardiac endpoints and gene expression in D. 26 
magna are partially similar but distinguishable from the observations in different organisms. 27 
No effect was observed on heart size growth in PRO and isoprenaline (ISO) exposure. The 28 
contraction capacity of the heart was decreased in ISO exposure, and the heart rate was 29 
decreased in PRO exposure. Time-series exposures showed different magnitudes of effect on 30 
heart rate and gene expression dependent on the type of chemical exposure. Significant 31 
enrichment of gene families involved in protein metabolism and biotransformation was 32 
observed within the differentially expressed genes, and we also observed differential 33 
expression in juvenile hormone-inducible proteins in ISO and PRO exposure, which is 34 
suspected of having endocrine disruption potential. Taken together, deviation between the 35 
effects of PRO and ISO in D. magna and other organisms suggests dissimilarity in MOAs or 36 
attributes of target bio-molecules between species. Additionally, PRO and ISO may act as 37 
endocrine disruptors based on the gene expression observation. Results in the present study 38 
confirm that it is challenging to predict ecological impact of active pharmaceutical 39 
ingredients (APIs) based on the available data acquired through human-focused studies. 40 
Furthermore, the present study provided unique data and a case study on the impact of APIs 41 
in a non-target organism.  42 
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Main Finding 47 
• Present study reveals that effects of β-adrenergic agents on heart function and gene 48 
expression of Daphnia magna are distinguishable from effects on other species despite partial 49 
similarity. 50 
 51 
 52 
1. Introduction 53 
 54 
APIs that are introduced into the aquatic environment can affect non-target organisms and, 55 
consequently, result in unintended harmful effects on ecosystems. Unexpected detrimental 56 
effects of APIs in natural ecosystems have been reported and are a pressing concern in 57 
environmental science (Brodin et al., 2013; Cuthbert et al., 2006; Pérez et al., 2012). Studies 58 
have proven that vertebrate biochemical messengers react with receptors in wildlife, which 59 
are potential targets of several APIs and responsible for crucial physiological functions in 60 
non-target organisms (Buonomo et al., 1984; Kashian and Dodson, 2004). Although the 61 
homology of pharmaceutical target receptors is highly species-dependent, studies have shown 62 
therapeutic actions of APIs in non-targeted organisms (Brooks and Huggett, 2012; Campos et 63 
al., 2012; Gunnarsson et al., 2008). Considering persistent concentrations of APIs up to 64 
several µg/L in the aquatic environment (Tijani et al., 2016), deeper understanding of the 65 
ecological risk of APIs is necessary to investigate how the effects of APIs occur and whether 66 
those are pharmacologically relevant.  67 
PRO, a cardiovascular drug, is one of the potentially harmful APIs to aquatic organisms. 68 
Results of our previous study on D. magna confirmed a heart-specific action of PRO in a 69 
non-target organism (Jeong et al., 2018), but details on the cardiac effects were limited due to 70 
the lack of observation on additional pharmacologically relevant endpoints. Furthermore, the 71 
complexity of the proposed MOAs of PRO in non-targeted organisms (Huggett et al., 2002; 72 
Massarsky et al., 2011) requires a study employing multiple biomarkers to further understand 73 
the effects and potential MOAs of the β-AR agent. Therefore, the current study focused on 74 
multiple pharmacologically relevant endpoints to investigate how β-AR binding agents affect 75 
D. magna. In addition, whole-body gene expression profiling in a time-course experiment 76 
was performed to provide deeper insight into the effects and potential MOAs. β-AR 77 
antagonist and agonist, PRO and ISO (Day and Roach, 1974), were used to activate and 78 
deactivate the target receptor. A mixture of the agents was also utilized to confirm a mixture 79 
effect as the effect of ISO is abolished by PRO (Hainsworth et al., 1973).  80 
 81 
2. Materials and Methods 82 
 83 
2.1. Preparation of chemical solutions and model organisms 84 
 85 
(±)-Propranolol hydrochloride and isoprenaline hydrochloride were purchased from Sigma-86 
Aldrich. Reagents were handled as recommended by the manufacturer. Chemical solutions 87 
for each exposure test were generated using media identical to the culture media. For the 88 
investigation of cardiac functional and structural change, an in-house D. magna culture was 89 
used. Culturing methods and media composition were in compliance with the US 90 
Environmental Protection Agency (EPA) guideline (Weber, 1991). For the gene expression 91 
profiling, the Xinb3 genotype of D. magna was used, which had been raised in the laboratory 92 
of K. D. Schamphelaere (Asselman et al., 2016). COMBO media and Organization for 93 
Economic Co-operation and Development (OECD) guidelines were used for the test 94 
organism culture (Kilham et al., 1998; OECD, 2012). The Xinb3 isolate was specifically 95 
selected for the gene expression profiling because it has been used to develop the recently 96 
published transcriptome of D. magna and allowed us to easily identify potential targets using 97 
the recently published corresponding gene set of D. magna (Orsini et al., 2016). 98 
 99 
 100 
 101 
Figure 1. Overall experiment design. 102 
 103 
 104 
2.2. Chemical exposure experiments and body sampling 105 
 106 
The overall design of the exposure experiments is described in Figure 1. The first and 107 
second experiments investigated the heart-related endpoints monitoring and whole body gene 108 
expression profiling, respectively. In the first experiment, animals were exposed to solutions 109 
of PRO and ISO during 6 days to study chronic effects in heart size, contraction capacity, and 110 
heart rate. The mixture of PRO and ISO was additionally used to investigate mixture effect of 111 
the target compounds on heart rate. The concentrations of solutions were 96 μg/L and 1,755 112 
μg/L for PRO and ISO solution, which are sub-lethal concentrations (Dzialowski et al., 113 
2006). Seven-day-old animals were individually exposed to each chemical solution in 30-mL 114 
plastic beakers. After 6 days of exposure, cardiac size, body size, and heart volumes in 115 
relaxation and contraction states were measured under the microscope. Every exposure was 116 
replicated 6 times.  117 
In the second experiment, animals were exposed for 24 h to 2 different concentrations of 118 
PRO, a single concentration of ISO, and a mixture of PRO and ISO to study changes in gene 119 
expression and heart rate. Five-day-old daphnids, which have no egg on their clutches, were 120 
used to avoid detection of gene expression in eggs. The solution concentrations were 0.9 121 
mg/L and 3.6 mg/L for PRO solutions, 84.4 mg/L for an ISO solution, and 0.9 mg/L of PRO 122 
and 84.4 mg/L of ISO for a mixture. The concentrations in the exposure were chosen to be 123 
sufficiently high to observe clear time-series changes of heart rate and corresponding gene 124 
expression regulation within 24 h, which is the period of initial response of D. magna to the 125 
exposed chemicals. Twenty individuals were exposed to different chemical solutions 126 
separately in a volume of 35 ml and were harvested at 1, 3, 6, and 24 h of exposure. When the 127 
whole body sample was gathered, heart rates were recorded from separate exposure sets, an 128 
individual D. magna in 20 mL chemical solutions, under a microscope. The body sampling 129 
was triplicated, and heart rate measurement was replicated 6 times. Exposure conditions, 130 
including room temperature and food concentration, were the same across all exposures and 131 
identical to the culturing conditions. Solutions in all exposures were daily generated and 132 
renewed daily to prevent degradation of the chemicals. 133 
 134 
2.3. Confirmation of chemical concentrations of solutions 135 
 136 
Chemical concentrations in the exposure solutions were quantified separately using liquid 137 
chromatography-tandem mass spectrometry (LC-MS/MS) in triplicate, and the averages of 138 
the estimated concentrations were used in this manuscript. The studies of Jeong et al. (Jeong 139 
et al., 2016) and Gu et al. (Gu et al., 2008) were used as references for analysis method 140 
development, and metoprolol was used as an internal standard compound. In brief, 141 
quantification was performed using a Waters Quattro micro high-performance LC-MS/MS 142 
system. Chromatographic separations were performed on an ACQUITY UPLC BEH C18 143 
column (2.1 × 150 mm, 3.5 µM, water). The mobile phases were Milli-Q water (0.1% formic 144 
acid) and acetonitrile (0.1% formic acid). The column temperature was 40℃. The mass 145 
condition was as follows: ESI positive ion mode; source temperature of 150℃; desolvation 146 
temperature of 350℃; desolvation gas flow of 500 L/h; nitrogen gas for desolvation, and 147 
argon gas for collision. The instrument was operated in multiple reaction monitoring mode 148 
and ion masses of 260>183, 208>166, and 268>74 were used for PRO, ISO, and metoprolol, 149 
respectively. 150 
 151 
2.4. Heart rate, heart size, and body size measurement from the 6-day exposure set 152 
 153 
Animals of similar body size were chosen to minimize biological variation. After 6 days of 154 
exposure, individuals were placed under a microscope (CKX41SF, Olympus) equipped with 155 
a digital camera, and heart rate, heart size, and body size were measured. The heart rate for 156 
30 sec was counted for 30s in slow-motion mode using a GOM player (Gretech Corporation), 157 
and relative heart rate to control was calculated for comparison between different exposures. 158 
The heart size and body size were captured and estimated using ImageJ software, and raw 159 
units (pixel) were not transformed to actual-size units (Schindelin et al., 2015). Heart size and 160 
body size were measured at the start and at the end of the exposure to calculate the relative 161 
change. To compare heart sizes between individuals, the measured heart size was normalized 162 
to the measured body size.  163 
The contraction capacity was defined as the area deduction between the heart sizes in 164 
relaxation and contraction states, and ImageJ was used for the measurements and calculations 165 
of the heart area. The details of the contraction capacity calculation are listed in Figure S1.  166 
 167 
2.5. Gene expression profiling and heart rate measurement from the 24-h exposure set 168 
 169 
During the 24-h exposure period, the animals were harvested after 1, 3, 6, and 24 h of 170 
exposure, at which heart rate was also simultaneously recorded. The measurement method of 171 
heart rate was the same as that in the 6-day exposure experiment. Body samples of D. magna 172 
frozen using liquid nitrogen were stored in 1.5 ml microtube at -80°C until RNA extraction. 173 
Total RNA was extracted from the body sample using the RNeasy kit and Qiashredder 174 
(Qiagen, Venlo, The Netherlands) following the manufacturer’s protocol.  175 
Concentration and quality of the extracted total RNA was measured using the Quant-it 176 
RiboGreen RNA assay (Life Technologies, Grand Island, NY, US) and using an RNA 6000 177 
Pico Chip Kit on a Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA, US). An 178 
Illumina mRNA sequencing library was made from 500 ng of total RNA using the Truseq 179 
stranded messenger RNA Library Prep Kit (Illumina, San Diego, CA, US). Libraries were 180 
quantified by quantitative polymerase chain reaction, according to Illumina's protocol 181 
Sequencing Library qPCR Quantification protocol guide. A DNA 1000 chip (Agilent 182 
Technologies, Santa Clara, CA, US) was used to control the library's size distribution and 183 
quality. In total, 21 RNA-sequence (RNA-seq) libraries were equimolarly pooled and 184 
sequenced on an Illumina NextSeq 500 high throughput run, generating 1 × 75 base pair 185 
reads. All sequencing data was deposited in GEO and is available under accession number 186 
GSE104487. 187 
 188 
2.6. Data analysis 189 
 190 
For the data from cardiac endpoints monitoring, an analysis of variance (ANOVA) test was 191 
performed with a post hoc Tukey’s test to compare the significant changes between exposure 192 
sets and control using SPSS 18.0.0 software. For the RNA-seq data, quality of the raw reads 193 
was assessed using FastQC (Babraham Institute, Cambridge, UK, version 0.11.5). Potential 194 
adapter contamination in the raw reads was removed using Trim Galore (Babraham Institute, 195 
Cambridge, UK, version 0.3.2.). Additionally, reads were dynamically trimmed to the longest 196 
stretch of bases to obtain at least 99.9% base-call accuracy. Reads were aligned to the Xinb3 197 
transcriptome (Orsini et al., 2016) using Bowtie2 (version 2.1.0) (Langmead and Salzberg, 198 
2012). Aligned reads were processed with HTseq to count the number of reads per gene 199 
(Anders et al., 2015). These counts files were then statistically analyzed in R and 200 
Bioconductor (Gentleman et al., 2004; Ihaka and Gentleman, 1996) for differential gene 201 
expression. Trimmed means of M-values were applied for normalization after data filtration. 202 
Quasi-likelihood dispersion was estimated (Lun et al., 2016). Gene expression at different 203 
time points and chemical exposures were compared with controls to identify significant 204 
differences using factorial designs to determine the effects of exposure time, PRO, ISO, and 205 
any potential interactions, e.g., interactions between PRO and time. This was done by fitting 206 
a quasi-likelihood negative binomial generalized log-linear model to the data and conducting 207 
gene-wise statistical tests for each statistical contrast or coefficient of the log-linear model, 208 
which includes both main effects and interaction effects (Lun et al., 2016). The Benjamini-209 
Hochberg method was applied to adjust p values (Benjamini and Hochberg, 1995). Genes 210 
with a significant p-value (<0.05) and a positive log2 fold change were identified as 211 
significantly upregulated, genes with a significant p-value and a negative log2 fold change 212 
significantly downregulated. No additional cut-off value was used. Fisher’s exact test was 213 
performed to identify enrichment or overrepresentation of gene families and pathways within 214 
the differentially expressed gene set (Asselman et al., 2012). 215 
 216 
3. Results  217 
 218 
3.1. Effect on heart rate, size, and contraction capacity after 6-day exposure 219 
 220 
The effects of PRO and ISO on cardiac structure and function were determined by 221 
measuring heart size, heart contraction capacity, and heart rate (Figure 2). Heart size did not 222 
significantly change after exposure to PRO and ISO (Figure 2a). However, heart contraction 223 
capacity decreased significantly in ISO exposure (Figure 2b). The heart rate measurement 224 
results are shown in Figure 2c. Heart rate was significantly reduced after 6 days of PRO 225 
exposure, whereas it was not affected by ISO. Interestingly, when ISO was mixed with PRO, 226 
the heart rate was significantly higher than when D. magna was exposed to PRO alone. The 227 
lowered heart rate in the mixture was still significantly decreased from that of the control.  228 
 229 
 230 
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Figure 2. (a) Heart size, (b) contraction capacity, and (c) heart rate after 6-day exposure. Each 
bar and line represents the average and ± standard error. *P ≤ 0.05. Propranolol and Isoprenaline 
were 96 μg/L and 1,775 μg/L, respectively. 
3.2. Heart rate and gene expression profile after 24 h exposure 231 
 232 
Time series effects of PRO and ISO on gene expression were monitored with timely 233 
synchronized heart rate measurement. The decrease in heart rate in D. magna was time-234 
dependent as well as dependent on types of exposures (Figure 3). PRO at 3.6 mg/L had the 235 
biggest effect on heart rate among all exposure conditions and the lowest heart rate was 236 
observed at 24 h. ISO did not have a significant effect, and the mixture of ISO and PRO 237 
resulted in a decrease in heart rate. However, this effect was smaller than that of PRO alone.  238 
 239 
 240 
Figure 3. Heart rate measurements for the different exposures at the different time points. 241 
Each scatter and line represent the average and ± standard error. Propranolol was 0.9 and 3.6 242 
mg/L for PRO 1 and 4, and Isoprenaline was 84.4 mg/L for ISO 100, respectively. 243 
 244 
At the gene expression level, we studied more than 19,000 genes and observed significantly 245 
different regulation of genes across exposures and time points. When comparing 246 
differentially expressed genes across the different statistical contrasts (Figure 4), we observed 247 
a similarity between the different contrasts. Eleven and 261 genes were shared across the 248 
different main contrasts and different interaction contrasts with time, respectively. These 249 
overlapping genes between the contrasts imply that gene expressions and consequent 250 
physiological changes might be partly overlapped as results of those gene expressions. In 251 
figure 4, the effects of PRO on gene expression seem to be more stable across different time 252 
points as we observed more than 1300 genes significantly expressed at all time points (PRO) 253 
whereas we observed roughly 400 genes which were significantly expressed depending on 254 
the time point (PRO X TIME). We observed the opposite for ISO and ISO + PRO. For those 255 
treatments, gene expression depends on the time point as more genes were significantly 256 
expressed in ISO X TIME and ISO + PRO X TIME contrast than the main effects. Based on 257 
these observations, it is assumable that ISO and ISO + PRO showed different level of 258 
influence dependent on time than PRO.  259 
 260 
 261 
Figure 4. Venn diagram of differentially expressed genes shared across different contrasts 262 
regardless of time (left): genes that differ significantly between control and PRO exposures 263 
regardless of time (PRO), between control and ISO exposures regardless of time (ISO), genes 264 
that show a significant interaction in a combined exposure of propranolol and isoprenaline 265 
regardless of time (ISO + PRO). Venn diagram of differentially expressed genes shared 266 
across different time contrasts (right): genes that showed a significant interaction between 267 
ISO and time (ISO X TIME), genes that showed a significant interaction between PRO and 268 
time (PRO X TIME), genes that showed a significant interaction between ISO and PRO 269 
exposures across time (ISO + PRO X TIME). 270 
 271 
The known main target of PRO and ISO is the β-AR, meaning that the changes in gene 272 
expression are not directly regulated by agents; however, it could provide hints on potential 273 
MOAs by comparing with results of previous studies focusing on effects of β-AR activity-274 
related agents. Table 1 compares MOA-related or frequently reported gene expressions from 275 
the present and previous studies. If there were too many genes annotated in a gene function to 276 
be summarized, only differentially expressed genes were listed in the table. As shown in 277 
Table 1, gene expression results are partially matched to the previous studies; the kinds of 278 
differentially expressed genes are quite similar but the patterns of gene expressions are far 279 
different. The details of all genes differentially expressed are provided in Table S2. 280 
 281 
Table 1. Differential gene expressions in this study and previous studies. Genes from 282 
previous studies are all regulated by β-AR activity-related agents. Up and Down arrows 283 
indicate up and downregulation of gene expression. ND: Differential expression not detected.  284 
Related 
function 
Observation References 
Gene Expression-Agent 
(across time) 
Expression-Agent 
(regardless of 
time points) 
Gene Expression - 
Agent 
Tissue 
β-Adrenergic 
receptor 
β-AR kinase  ND ND β1-AR ↑↓ - ISO Medaka 
heart 
(Kawasaki 
et al., 2008) 
β2-AR  ND ND 
Protein 
Kinase A 
Camp-dependent 
protein  
kinase catalytic 
subunit  
↑ - ISO 
↓ - ISO+PRO 
↓ - PRO 
Myosin Myosin light 
chain kinase,  
smooth muscle 
↑ - ISO, PRO 
↓ - ISO+PRO 
↓ - PRO Myosin 
XVIIIA 
↓ - PRO Minnow 
brain 
(Lorenzi et 
al., 2012) Myosin-RhoGAP 
protein  
↑ - ISO 
↓ - ISO+PRO 
↓ - PRO 
Unconventional 
Myosin 16 
↑ - ISO 
↓ - ISO+PRO 
↓ - PRO Myosin 
light chain 
↓ - PRO Burned 
patients 
muscle 
(Herndon et 
al., 2003) 
Myosin 3  ↓ - ISO  
Actin α -Actinin-1  ↑ - ISO 
↓ - ISO+PRO 
↓ - PRO skeletal α-
actin 
↑ - ISO Rat 
ventricular 
myocytes 
(Bishopric 
et al., 1992) 
Apoptosis B-cell 
lymphoma/leuke
mia 11A  
↓ - ISO+PRO ND Caspase 8 ↓ - PRO Minnow 
brain 
(Lorenzi et 
al., 2012) Tumor necrosis 
factor ligand  
superfamily 
member  
↑ - ISO ↓ - PRO Caspase 3 ↓ - PRO 
Calcium/calmodul
in dependent  
protein kinase 
↑ - ISO 
↓ - ISO+PRO 
↓ - PRO TGF-β3 ↓- ISO Rat cardiac 
fibroblasts(
Colombo et 
al., 2001) 
Immediate 
early gene 
c-Fos ND ND c-Fos ↑- ISO+CHT Rat 
myocardial 
cell, Rat 
ventricular 
tissue 
(Brand et 
al., 1993; 
Iwaki et al., 
1990) 
c-Jun ↑- ISO+CHT Rat 
myocardial 
cell (Iwaki 
et al., 1990) 
Jun-B ↑ - ISO Rat 
ventricular 
tissue 
(Brand et 
al., 1993) 
Early growth 
response 
ND ND Jun-D ↑ - ISO Rodent 
parotid 
gland (Ten 
Hagen et al., 
2002) 
Early 
growth 
response 1 
↑-ISO+CHT Rat 
myocardial 
cell (Iwaki 
et al., 1990) 
 285 
 286 
Apart from the expression analysis on the single genes, we observed the enrichment of 287 
several gene families with differentially expressed genes in ISO, PRO, and mixture exposures 288 
(Table S1, Figure 5, 6 and 7). Given the small number of genes for the main ISO and ISO × 289 
PRO contrasts, few significant enrichments could be detected (Table S1, Figure 5, 6 and 7), 290 
and, as such, gene family enrichment for the contrasts without time interactions will not be 291 
discussed further. Eight gene families were significantly enriched with differentially 292 
expressed genes across the different exposures in time x exposure interactions (Table 2, 293 
Figure 5, 6 and 7). For all gene families, the largest upregulation was observed after 6 or 24 h 294 
for the PRO exposure as shown in the case of PRO exposure (Figure 5). In addition, we 295 
observed dose-dependent gene expression after 6 h for all these gene families for the different 296 
PRO exposures (Figure 6). For all gene families, the gene expression patterns can be 297 
described as similar for all exposures. Only C-type lectin and carboxylesterase gene families 298 
showed different regulation patterns by the mixture of PRO and ISO at 6 h, suggesting a 299 
potential mixture interaction between the effects of ISO and PRO at the gene level.  300 
 301 
Figure 5. Average gene expression patterns for different gene families in PRO 0.9 mg/L 302 
relative to control exposure across four time points. (e.g., Value 1 means that normalized 303 
counts per million are equal in propranolol and control exposures). Error bars represent 304 
standard errors.  305 
 306 
 307 
 308 
309 
 310 
Figure 6. Average gene expression patterns for different gene families in PRO 1 mg/L (blue), 311 
PRO 4 mg/L (purple), ISO 100 mg/L (red), PRO 1mg/L + ISO 100 mg/L (green) across two 312 
time point. 313 
Among the gene families significantly enriched, only 2 gene families were enriched by ISO 314 
and PRO individually, but not by ISO + PRO. Surprisingly, these 2 gene families showed a 315 
time-dependent pattern for ISO, while they showed a consistent pattern over time for PRO 316 
(Figure 7, Table S1). Indeed, ISO exposure across time regulated genes, which have 317 
endocrine disrupting (ED) potential, the juvenile hormone inducible proteins while this was 318 
regulated significantly but consistently regulated over time in PRO (Figure 7, Table S1). 319 
Similarly, the mRNA capping enzymes are significantly enriched in the ISO X TIME and in 320 
the PRO contrast, but not in any others. These genes are involved in gene expression and 321 
splicing. While it seems likely that exposure to toxicants affects gene expression and splicing, 322 
it is unclear as to why these effects are observed for the single stressors but not for the 323 
combined treatment. 324 
 325 
Figure 7. Average gene expression patterns for the juvenile hormone inducible proteins in 326 
PRO 1 mg/L (blue), PRO 4 mg/L (purple), ISO 100 mg/L (red), PRO 1mg/L + ISO 100 mg/L 327 
(green) across two time points. Error bars represent standard errors.  328 
 329 
4. Discussion  330 
 331 
4.1. Effect on cardiac structure and function after 6-day exposure 332 
 333 
Heart size is known to be affected by β-AR activity (Osadchii, 2007; Stanton et al., 1969). 334 
Abnormal enlargement of the heart, or cardiomegaly, has been reported to be induced by β-335 
AR activation via ISO administration in rats (Osadchii, 2007; Stanton et al., 1969). Both PRO 336 
and ISO have demonstrated negative and positive effects in the heart size of fish (Kawasaki 337 
et al., 2008). Here, the size of the heart of D. manga was not affected (Figure 2a). In addition, 338 
the results of contraction capacity were not comparable to previous studies (Figure 2b). In 339 
general, cardiac output, which is a function of the heart rate and stroke volume, is known to 340 
be increased by ISO (McQueen et al., 2005) with increases in both heart rate and stroke 341 
volume (Fenyvesi and Hadházy, 1973; Kouchoukos et al., 1970). Because the stroke volume 342 
is the amount of blood per heartbeat, the contraction capacity must be positively related to the 343 
stroke volume. As the reduction of the contraction capacity in this study implies a potential 344 
reduction in stroke volume, the effect caused by ISO contrasts with the results of previous 345 
studies, in which an increase in heart rate and stroke volume were reported. 346 
ISO and PRO are known to have opposite regulatory effects on the heart rate in humans, 347 
and PRO is able to negate the effect of ISO (Brick et al., 1968). The decreased heart rate in 348 
the PRO exposure group, and the decreased but higher level than that of PRO alone in the 349 
mixture, supports a similar action of the chosen drugs in D. magna (Figure 2c, 3). On the 350 
other hand, no change in ISO exposure suggests a weak binding affinity or a difference in 351 
pharmacodynamics of ISO in the heart of D. magna. Berghmans et al. reported a non-352 
significant mild increase of zebrafish heart rate at 1 mM of ISO exposure; otherwise, gut 353 
contraction was severely affected in the same exposure condition (Berghmans et al., 2008). 354 
Their results are comparable to ours in terms of the influence of ISO on certain biological 355 
functions, but not heart rate, in non-targeted organisms. 356 
Overall, the observed responses in D. magna hearts highlight clear differences from the 357 
known actions of PRO and ISO. We observed effects partially identical to the 358 
pharmacological effects on heart rate, but the observations on heart size and contraction 359 
capacity were totally unpredictable from the known MOA. It is assumed that the discrepancy 360 
in actions of the APIs results from structural differences of target receptors or variations in 361 
the distribution and function of target receptors between species. Such species deviations 362 
have been reported; for example, β2-AR activation induces a positive inotropic response in 363 
myocytes of cats and dogs, but not in guinea pigs, due to variations in receptor distribution 364 
and physiological function (Booze et al., 1989; Steinberg, 1999). Different amino acid 365 
sequences of target receptor subtypes could also contribute to functional differences (Finch et 366 
b 
al., 2006; Michel and Insel, 2006). Because these differences occur between relatively closely 367 
related mammals, it is not surprising that differences exist between mammals and D. magna, 368 
and this supports a predicted low similarity of β2-AR between Daphnia and humans based on 369 
genome sequence data (Gunnarsson et al., 2008).  370 
 371 
4.2. Effect on whole-body gene expression during 24 h exposure 372 
 373 
In figure 4, more stable effects on gene expression were observed across time in PRO than 374 
ISO and ISO + PRO. This may suggest that the pathways triggered by PRO require 375 
continuous expression whereas the pathways triggered by ISO and ISO + PRO require 376 
subsequent expression of different genes over different time points. Temporal patterns for 377 
gene expression have already been observed for metallothionein genes in response to metal 378 
exposure most likely due to the long half-life of metallothionein proteins (Asselman et al. 379 
2013). As such, this could also suggest that genes regulated by PRO encode for proteins with 380 
a shorter half-life, thus leading to more continuous RNA expression, while genes regulated 381 
by ISO and ISO + PRO encode for proteins with a long half-life, thus requiring only RNA 382 
expression at specific time points. 383 
Table 1 shows similar genes were affected in expression but the patterns of gene expression 384 
were different compared to the previous studies. This tendency is in the same context of the 385 
observed impacts on the cardiac endpoints in this study. β-AR activity has been known to be 386 
involved to muscle contraction, cell growth, apoptosis and a variety of other functions in 387 
different organs, particularly in the heart (Communal et al., 1998; Devic et al., 2001; Simpson 388 
et al., 1991). In the major signaling pathway, stimulation of β-AR results in a signaling 389 
cascade sequentially consisting of G protein-mediated adenylyl cyclase activation, c-AMP 390 
generation, PKA activation, and phosphorylation of diverse proteins, which leads to 391 
physiological changes (Perez, 2006). β1-AR gene, a gene of the target receptor of PRO and 392 
ISO, did not influence the expression, unlike the up- and downregulation by ISO in the fish 393 
model (Kawasaki et al., 2008). Cyclic adenosine monophosphate (cAMP)-dependent protein 394 
kinase (PKA), a major downstream enzyme, phosphorylates various substrates in the AR 395 
signaling pathway; for example, the L-type Ca2
+ channel is phosphorylated by PKA and the 396 
increased inner cell Ca2+ concentration of myocytes (Perez, 2006). Expression of the PKA 397 
catalytic subunit gene was up- and downregulated by agents and its mixture in the present 398 
study. Myosin-related gene expressions were reported to be downregulated by PRO in fish 399 
and burned patients (Herndon et al., 2003; Lorenzi et al., 2012). In the present study, several 400 
myosin-related gene expressions were significantly regulated by drug exposures; a mixture 401 
and solutions of PRO and ISO up and downregulated most of the gene expressions, except 402 
Myosin-3, which is downregulated by ISO only. Actin is supposed to be related to muscle 403 
cell morphological and developmental regulation along with myosin. A study found that gene 404 
expression of the skeletal α-actin is upregulated by ISO in rat ventricular myocytes 405 
(Bishopric et al., 1992). Expression of the α-actinin-1 was found to be up and downregulated 406 
by the mixture and single solutions of PRO and ISO. Apoptosis mediated by β1-AR activation 407 
has been reported (Communal et al., 1999) and in-vitro studies have revealed that myocyte 408 
apoptosis results from PKA-independent activation of calcium/calmoduline-dependent 409 
kinaseⅡ (CaMKⅡ) (Zhu et al., 2003). Differential expressions of the gene related to 410 
apoptosis and CaMKⅡ are detected in the present study, but the impacts on gene expression 411 
were not comparable to those of previous studies. Additionally, early response gene 412 
expressions were compared to those of the previous studies; however, there was also lack of 413 
similarity. 414 
Obviously, there are limitations in the comparison of gene expression between studies. The 415 
studies used different organisms, tissues, effect concentrations, and exposure times. 416 
Complexity of the MOA of agents is another factor making the translation of gene expression 417 
results challenging; for example, ISO and PRO also targets mitogen-activated protein kinase 418 
1 (MAPK1), phosphatidylinositol 3-kinase regulatory subunit alpha (PIK3R, 419 
phosphodiesterase 4 (PDE4), superoxide dismutase 1 (SOD1), and 5-HTR1, which share so 420 
many molecules in their cascade signaling pathways with β-AR pathway (Masson et al., 2012; 421 
Wishart et al., 2017). Although there are uncertainties caused by the limitations, it seems 422 
clear that PRO and ISO affect genes involved in the AR pathway, and the patterns of gene 423 
expressions are quite different from the previous studies, as shown in Table 1, which is in the 424 
same context of physiological monitoring results because the results are only partially 425 
comparable to those of other organisms.  426 
Table 2 shows that most of the gene families that were significantly enriched are related to 427 
protein metabolism. Carboxypeptidase (Carboxypeptidase B and Zinc Carboxypeptidase) is 428 
responsible for the hydrolytic cleavage of a peptide bond at the C-terminal of protein or 429 
polypeptide (Christianson and Lipscomb, 1989). Serine protease (serine protease, trypsin 430 
serine protease, and chymotrypsin) also cleaves peptide bonds; trypsin-like and 431 
chymotrypsin-like protease respectively target basic and non-polar amino acids (Ovaere et al., 432 
2009). Those protein-degrading enzymes are involved in a wide range of biological functions, 433 
including digestion, immune response, reproduction, and protein post-translation 434 
modification (Hedstrom, 2002). According to a recent observation, PRO exposure caused a 435 
depletion of free amino acids in the D. magna metabolome (Jeong et al., 2018). The present 436 
results are not sufficient to suggest which specific mechanisms result in the gene family 437 
enrichments; however, as the peptide-cleaving enzymes are related to the protein metabolism, 438 
the enrichment of the 5 gene families in this study may be associated with the downregulation 439 
of the free amino acid contents. In addition to the carboxypeptidase and protease, the other 2 440 
gene families are related to biotransformation. Carboxylesterase and UDP are individually 441 
phaseⅠand Ⅱ enzymes (Parkinson and Ogilvie, 2001). They catalyze hydrolysis and 442 
glucuronidation of xenobiotics. It was confirmed from our previous study that a major 443 
metabolite of PRO in humans is also generated by D. magna (Jeong et al., 2016); thus, the 444 
gene family enrichment related to the drug metabolism seems rational. 445 
 446 
Table 2. Overview of the gene families that were enriched for differentially expressed genes 447 
in statistic contrasts: (1) genes that differed significantly between PRO and control exposures 448 
across time: PRO X TIME; (2) genes that showed a significant interaction between ISO and 449 
control exposures across time: ISO X TIME; (3) genes that differed significantly between 450 
ISO and PRO exposures across time: ISO + PRO X TIME. P values are Benjamini-Hochberg 451 
adjusted P values and the result of Fisher exact test for enrichment analysis. Visualization of 452 
the gene expression patterns can be found in Figures 5, 6 and 7. 453 
 PRO X TIME ISO X TIME ISO + PRO X 
TIME 
C-type lectins 9.52 e-04 5.4 e-15 9.53 e-16 
Carboxypeptidase B 1.51 e-05 4.04 e-04 2.55 e-05 
Chymotrypsin BI precursor 2.78 e-05 8.72 e-04 1.53 e-04 
Carboxylesterase 3.00 e-09 6.22 e-08 6.66 e-10 
Putative serine protease 7.68 e-06 1.24 e-04 7.63 e-06 
Trypsin serine protease 1.15 e-04 8.72 e-04 9.30 e-05 
UDP-glucorosonyltransferase 2A1 8.67 e-04 5.69 e-05 2.4 e-06 
Zinc carboxypeptidase 8.57 e-03 2.25 e-06 6.66 e-10 
 454 
The ED ability of APIs has been discussed in previous studies, and AR drugs were also 455 
mentioned as a potential ED chemical (Massarsky et al., 2011). Despite the structural 456 
similarity between PRO and ISO, only ISO showed time-dependent impacts on ED-related 457 
gene expressions (Figure 7). It seems needed to be further studied about the effect of ISO on 458 
D. magna requires further study, as ISO showed distinguishable and significant impacts on 459 
cardiac endpoints along with the ED-related gene expression.  460 
 461 
5. Conclusion 462 
Our results highlight that effects of PRO and ISO on a non-target species, D. magna, is 463 
unpredictable, as indicated in the available pharmacological database. Cardiac endpoints and 464 
gene expression in D. magna were affected by PRO and ISO in a manner similar to that of 465 
other organisms, but the results do not seem to be extrapolatable based on the results of other 466 
species. Furthermore, enrichment analysis indicated that AR drugs affect to expression of 467 
genes involved in protein metabolism, drug metabolism and, more importantly, endocrine 468 
system disruption which suggests needs for future studies for ED potential of ISO and PRO. 469 
Although this study still has limitations in study design to reveal MOAs precisely, at the same 470 
time, it proves the novelty of co-employment of physiological and transcriptional 471 
measurements in the investigation of impacts on APIs in non-target species study. 472 
 473 
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